These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 32567740)
1. THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway. Guo D; Zhang D; Ren M; Lu G; Zhang X; He S; Li Y FASEB J; 2020 Aug; 34(8):10668-10681. PubMed ID: 32567740 [TBL] [Abstract][Full Text] [Related]
2. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related]
3. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
4. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294 [TBL] [Abstract][Full Text] [Related]
5. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway. Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122 [TBL] [Abstract][Full Text] [Related]
6. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway. Hou Y; Li H; Huo W Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318 [TBL] [Abstract][Full Text] [Related]
8. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858 [TBL] [Abstract][Full Text] [Related]
9. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma. Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550 [TBL] [Abstract][Full Text] [Related]
10. TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma. Liu K; Wu X; Zang X; Huang Z; Lin Z; Tan W; Wu X; Hu W; Li B; Zhang L Oncol Res; 2017 Sep; 25(8):1329-1340. PubMed ID: 28256185 [TBL] [Abstract][Full Text] [Related]
11. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN. Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
15. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling. Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214 [TBL] [Abstract][Full Text] [Related]
16. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma. Ge JC; Wang YX; Chen ZB; Chen DF Cell Signal; 2020 Feb; 66():109465. PubMed ID: 31698037 [TBL] [Abstract][Full Text] [Related]
17. Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma. Su F; Zhao J; Qin S; Wang R; Li Y; Wang Q; Tan Y; Jin H; Zhu F; Ou Y; Cheng Z; Su W; Zhao F; Yang Y; Zhou Z; Zheng J; Li Y; Li Z; Wu Q Oncotarget; 2017 Apr; 8(14):23277-23288. PubMed ID: 28177895 [TBL] [Abstract][Full Text] [Related]
18. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275 [TBL] [Abstract][Full Text] [Related]
19. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway. Ni Q; Chen Z; Zheng Q; Xie D; Li JJ; Cheng S; Ma X Cancer Sci; 2020 May; 111(5):1500-1513. PubMed ID: 31997489 [TBL] [Abstract][Full Text] [Related]
20. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]